Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label crossover trial to investigate the efficacy of treatments in apomorphine-induced skin reactions
2014-000657-36Phase 2Terminated
- Sponsor
- University Medical Center Groningen
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of hydrocortisone in Parkinson's disease (PD) and apomorphine-induced skin reactions, sponsored by University Medical Center Groningen. Primary endpoint: Global Perceived Effect (GPE) scale change. Started Jun 2015; status: terminated.
02
Drugs
hydrocortisone
03
Conditions
Parkinson's disease (PD)apomorphine-induced skin reactions
Beyond the preview
Go deeper on 2014-000657-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000657-36.